Understand the source comparison
How to Inject Snap-8 Subq: Dosing Comparison
Snap-8 (Acetyl Octapeptide-3) 0.1–0.5mg per site 1–2mg/mL in bacteriostatic water Daily to twice daily 27–30G insulin syringe 2–8°C, use within 28 days Requires slow injection to prevent peptide shearing; do not massage post-injection BPC-157 250–500mcg per si
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Snap-8 (Acetyl Octapeptide-3)
- 0.1–0.5mg per site
- 1–2mg/mL in bacteriostatic water
- Daily to twice daily
- 27–30G insulin syringe
- 2–8°C, use within 28 days
- Requires slow injection to prevent peptide shearing; do not massage post-injection
- BPC-157
- 250–500mcg per site
- 1mg/mL in bacteriostatic water
- Once or twice daily
- 29–31G insulin syringe
- 2–8°C, stable 60+ days
- More stable than Snap-8; can tolerate brief temperature excursions
- Matrixyl (Palmitoyl Pentapeptide)
- 0.2–1mg per site
- 2–5mg/mL in bacteriostatic water
- Once daily
- 2–8°C, use within 21 days
- Higher concentration possible due to better solubility; similar injection technique
- Copper Peptides (GHK-Cu)
- 1–3mg per site
- 5–10mg/mL in bacteriostatic water
- 2–8°C, unstable beyond 14 days
- Oxidizes rapidly; prepare in small batches
- Snap-8's acetyl modification improves skin penetration but reduces stability compared to non-acetylated peptides. Researchers using Snap-8 subcutaneously report better consistency with daily fresh-draw protocol. Preparing syringes in advance increases degradation risk even under refrigeration.